Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Padsevonil adjunctive dose-finding study in adults with drug-resistant focal epilepsy
2017-003200-48Phase 2Completed
- Sponsor
- UCB
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of padsevonil in Focal Onset Epilepsy, epilepsy, sponsored by UCB. Started Dec 2017; status: completed.
02
Drugs
padsevonil
03
Conditions
Focal Onset Epilepsyepilepsy
Beyond the preview
Go deeper on 2017-003200-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003200-48.